Vancomycin Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-149

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vancomycin Hydrochloride (NDC 25021-149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Van0w 0000 01)

Chemical structure of Vancomycin Hydrochloride, showing the detailed molecular arrangement including rings, side chains, and functional groups. This structure corresponds to the active ingredient Vancomycin Hydrochloride in the injection powder form.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Van0w 0000 02)

Label for Vancomycin Hydrochloride for Injection, USP, 750 mg per vial, sterile powder in a single-dose vial for intravenous use. The label includes handling instructions such as dilution before use, storage recommendations, and manufacturer information for Sagent Pharmaceuticals. The label also features NDC 25021-147-20 and barcode details.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Van0w 0000 03)

Label for Vancomycin Hydrochloride for Injection, USP 1.25 grams per vial, sterile powder single-dose vial for intravenous use. The label includes dosage preparation instructions, storage conditions, preservative-free indication, manufacturer Sagent Pharmaceuticals, and barcode. It also states that after reconstitution the drug must be further diluted and refrigerated.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Van0w 0000 04)

Vancomycin Hydrochloride for Injection, USP 1.5 grams per vial label for intravenous use. The label states it is a sterile powder in a single-dose vial and emphasizes that after reconstitution, the solution must be further diluted. The label includes manufacturer information for Sagent Pharmaceuticals and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.